WO2012100083A3 - Human induced neuronal cells - Google Patents
Human induced neuronal cells Download PDFInfo
- Publication number
- WO2012100083A3 WO2012100083A3 PCT/US2012/021910 US2012021910W WO2012100083A3 WO 2012100083 A3 WO2012100083 A3 WO 2012100083A3 US 2012021910 W US2012021910 W US 2012021910W WO 2012100083 A3 WO2012100083 A3 WO 2012100083A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- human induced
- hin
- fibroblast
- induced neuronal
- neuronal cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0619—Neurons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1307—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
A method for reprogramming a fibroblast into a human induced neuronal cell (hIN) is described. The method comprises expressing heterologous reprogramming factors Bm2, Myt11, Zicl, Olig2, Asc11 or any combination thereof, in said fibroblast, and culturing the fibroblast in a medium comprising BDNF, NT3, GeM or any combination thereof. Biomarkers describing the obtained hiN cells are also presented. In another aspect, methods for screening compounds using the hiN cells is described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/980,832 US20140193341A1 (en) | 2011-01-19 | 2012-01-19 | Human induced neuronal cells |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161434190P | 2011-01-19 | 2011-01-19 | |
US61/434,190 | 2011-01-19 | ||
US201161505407P | 2011-07-07 | 2011-07-07 | |
US61/505,407 | 2011-07-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012100083A2 WO2012100083A2 (en) | 2012-07-26 |
WO2012100083A3 true WO2012100083A3 (en) | 2012-09-20 |
Family
ID=46516380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/021910 WO2012100083A2 (en) | 2011-01-19 | 2012-01-19 | Human induced neuronal cells |
Country Status (2)
Country | Link |
---|---|
US (1) | US20140193341A1 (en) |
WO (1) | WO2012100083A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6335117B2 (en) * | 2012-03-21 | 2018-05-30 | 国立大学法人京都大学 | Method for screening therapeutic and / or prophylactic agent for Alzheimer's disease |
US9730975B2 (en) | 2014-11-25 | 2017-08-15 | The Penn State Research Foundation | Chemical reprogramming of human glial cells into neurons for brain and spinal cord repair |
US11027047B2 (en) | 2015-03-31 | 2021-06-08 | The University Of North Carolina At Chapel Hill | Delivery vehicles for stem cells and uses thereof |
US20200123499A1 (en) * | 2015-12-02 | 2020-04-23 | Massachusetts Institute Of Technology | Method for efficient generation of neurons from non-neuronal cells |
WO2017223052A1 (en) * | 2016-06-20 | 2017-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | Biologically relevant in vitro screening of human neurons |
US20200377885A1 (en) * | 2017-08-07 | 2020-12-03 | Washington University | Compositions and methods for the generation of neurons and uses thereof |
KR102203860B1 (en) * | 2019-05-24 | 2021-01-15 | 주식회사 아이피에스바이오 | Induced pluripotent stem cells having presenilin protein mutants(E120K) derived from Alzheimer's disease patients |
WO2023283577A1 (en) * | 2021-07-06 | 2023-01-12 | Washington University | Compositions and methods for the generation of neurons and uses thereof |
WO2023039503A2 (en) * | 2021-09-10 | 2023-03-16 | Alnylam Pharmaceuticals, Inc. | App irna compositions and methods of use thereof for treating or preventing diseases characterized by enlarged endosomes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2000479A1 (en) * | 1995-04-28 | 2008-12-10 | HSC Research and Development Limited Partnership | Genetic Sequences and Proteins Related to Alzheimer's Disease, and Uses Therefor |
US7632680B2 (en) * | 2001-08-08 | 2009-12-15 | Levesque Biosciences, Inc. | Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
US20100167286A1 (en) * | 2008-06-24 | 2010-07-01 | Parkinson's Institute | Pluripotent cell lines and methods of use thereof |
-
2012
- 2012-01-19 WO PCT/US2012/021910 patent/WO2012100083A2/en active Application Filing
- 2012-01-19 US US13/980,832 patent/US20140193341A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2000479A1 (en) * | 1995-04-28 | 2008-12-10 | HSC Research and Development Limited Partnership | Genetic Sequences and Proteins Related to Alzheimer's Disease, and Uses Therefor |
US7632680B2 (en) * | 2001-08-08 | 2009-12-15 | Levesque Biosciences, Inc. | Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof |
US20100167286A1 (en) * | 2008-06-24 | 2010-07-01 | Parkinson's Institute | Pluripotent cell lines and methods of use thereof |
Non-Patent Citations (2)
Title |
---|
KIM ET AL.: "Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity", STEM CELL REV., vol. 6, no. 2, June 2010 (2010-06-01), pages 270 - 281, XP055007831, DOI: doi:10.1007/s12015-010-9138-1 * |
VIERBUCHEN ET AL.: "Direct conversion of fibroblasts to functional neurons by defined factors", NATURE, vol. 463, no. 7284, 25 February 2010 (2010-02-25), pages 1035 - 1041, XP055023150, DOI: doi:10.1038/nature08797 * |
Also Published As
Publication number | Publication date |
---|---|
US20140193341A1 (en) | 2014-07-10 |
WO2012100083A2 (en) | 2012-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012100083A3 (en) | Human induced neuronal cells | |
IL265470B (en) | Culture medium composition, and method for culturing cell or tissue using said composition | |
EP3460042A4 (en) | Cell culture medium for culturing organoid, culture method, and organoid | |
EP2639293A4 (en) | Cell culture chamber, method for producing same, tissue model using cell culture chamber, and method for producing same | |
EP2304326A4 (en) | Cross-pleated membrane cartridges, and method and apparatus for making cross-pleated membrane cartridges | |
WO2010011644A3 (en) | Differentiated anucleated cells and method for preparing the same | |
GB2411178B8 (en) | Apparatus and method for preparing and culturing cells | |
EP2589652A4 (en) | Disposable set for cell culture, cell culture device and cell preparation method | |
EP2270126A4 (en) | Cell selection apparatus, and cell selection method using the same | |
ZA201101167B (en) | Increased heterologous fe-s enzyme activity in yeast | |
EP2204643A4 (en) | Cell analysis apparatus and cell analysis method | |
EP2202291A4 (en) | Culture apparatus, culture information management method, and program | |
EP2549396A4 (en) | Method for simulating magnetic material, and program | |
EP2692853A4 (en) | Membrane-separation-type culture device, membrane-separation-type culture kit, stem cell separation method using same, and separation membrane | |
EP2570969A4 (en) | Apparatus and method for iris recognition using multiple iris templates | |
EP2438161B1 (en) | Method for producing induced pluripotent stem cells and method for culturing the same | |
EP1859817A4 (en) | Cultured cell sheet, process for producing the same and method for restoring tissue using the same | |
EP2647705A4 (en) | Flavin-bound glucose dehyrogenase, production method for flavin-bound glucose dehyrogenase, and yeast transformant used in same | |
EP2420711A4 (en) | Valve block, valve block unit, and method for inspecting the valve block unit | |
EP2961689A4 (en) | Sulfur-carbon composite for lithium-sulfur battery, the method for preparing said composite, and the electrode material and lithium-sulfur battery comprising said composite | |
EP2423840A4 (en) | Molding simulation method, molding simulation device, molding simulation program, and recording medium therefor | |
HK1143404A1 (en) | Cell for use in the production of exogenous protein, and production process using the cell | |
EP2162531A4 (en) | Method and means for culturing osteoblastic cells | |
EA201300780A1 (en) | METHOD FOR OBTAINING INDUCED PLURIPOTENT STEM CELLS AND DIFFERENTIATED CELLS | |
EP2657304A4 (en) | Azo dye, ocular lens material, method for producing ocular lens material, and ocular lens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12737021 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12737021 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13980832 Country of ref document: US |